Apogee Therapeutics CMO Carl Dambkowski disposes of USD 737,935 in common shares
APGE•Chief medical officer sells shares, exercises options
- Apogee Therapeutics Chief Medical Officer Carl Dambkowski sold 5,500 shares on Aug. 5 at USD 134.17.
- He exercised stock options for 4,125 shares the same day at USD 22.86.
- Directly held common stock ended at 168,498 shares.
- Directly held stock options ended at 110,665.
Related News
Palisade Bio wins FDA IND clearance for PALI-2108 Crohn’s disease Phase 2 trial
PALI•
Jinxin Technology management says H1 2026 revenue drop driven by weaker telecom distributor membership card sales
NAMI•
